Omentectomy Versus Omental Preservation During Gastrectomy for Gastric Cancer: Systematic Review and Reconstructed Individual Patient Data Meta-Analysis
In brief
Routine omentectomy did not improve survival and raised complications 17%
In a meta-analysis of 15 studies and 5,325 patients undergoing gastrectomy for gastric cancer, removing the omentum did not improve overall or disease-free survival at five years compared with preserving it. Omentectomy was linked to 17% more overall complications, more blood loss and a slightly longer hospital stay; randomized trials are still needed to confirm whether preservation is appropriate for more patients.
- Journal
- Journal of clinical medicine (Q1)
- Published
- 1 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Alberto Aiolfi, Antonio Farro, Matteo Calì, Francesco Cammarata, Calin Popa, Gianluca Bonitta, et al.
- PMID
- 43030639
- DOI
- 10.3390/jcm15218495
Why clinicians should know about it
- Picked for Surgery (top studies of the week, 15 November 2026): Meta-analysis informs extent of gastrectomy for gastric cancer
Abstract
Background/Objectives: The oncological benefit of routine omentectomy (OmR) during curative gastrectomy for gastric cancer (GC) remains controversial. While omentectomy has traditionally been performed to reduce peritoneal dissemination, the greater omentum also possesses immunological functions that may protect against tumor implantation. This study evaluated the impact of OmR versus omental preservation (OmP) on long-term survival using reconstructed individual patient data (IPD) and restricted mean survival time difference (RMSTD) meta-analysis. Methods: A systematic review was conducted according to PRISMA 2020 guidelines. Comparative studies reporting Kaplan-Meier curves for overall survival (OS) and/or disease-free survival (DFS) after OmR versus OmP were included. IPD were reconstructed from published survival curves, and pooled RMSTD estimates were calculated using random-effects multivariate meta-analysis. Flexible hazard-based regression models assessed time-varying treatment effects. Secondary outcomes included postoperative morbidity and operative outcomes. Results: Fifteen studies involving 5325 patients were included, of whom 54% underwent OmR. At 60 months, no significant difference in OS was observed for OmR vs. OmP (-0.79 months, 95% CI -2.13 to 0.54). Similarly, DFS did not differ significantly (-2.12 months, 95% CI -4.59 to 0.35). Time-varying hazard analyses demonstrated no survival advantage for OmR throughout follow-up. OmR was associated with significantly higher intraoperative blood loss (MD 42.9), overall complications (RR 1.17), and longer hospital length of stay (MD 0.49). Retrieved lymph nodes, anastomotic leak, operative time, and 30-day mortality were comparable. Conclusions: In this study, routine omentectomy during gastrectomy for gastric cancer was not associated with improved OS or DFS compared with omental preservation. These findings question the need for routine omentectomy and suggest that omental preservation may represent a reasonable surgical strategy in selected patients, pending confirmation from prospective randomized trials.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.